Industry knowledge, webinars and more for clinical research sites
Team CRIO is excited to announce that 24-hour live chat support is now available for our global network of users. Over the last year, we’ve onboarded hundreds of new sites worldwide. And when you need help, one of CRIO’s skilled experts will be on-hand to give you the answers you need, fast. Here’s a recap of support...
Here’s something new we know you’ll love. Do more with better data when your site enables CRIO’s Recruiting API. Now sites can perform recruitment activities outside of CRIO by integrating with their preferred recruiting vendor platforms to digitally capture patient leads. Vendors can send patient updates, qualify patients into studies, schedule appointments, and more. Essentially,...
Mark Joing is the Founder & CEO at Mojo Trials, a startup life sciences service provider delivering virtual site monitoring in clinical trials. He is also the Chief Operating and Financial Officer at Sanaby Health, a Special Purpose Acquisition Company created to accelerate innovation in healthcare. His 25+ year career in biopharma includes executive roles...
Bridging the gap eSource is the bridge between the protocol and the eCRF fields. To understand why, we need to understand what each does. The protocol describes the purpose of the study, the core hypotheses, the endpoints that are to be collected, and the resulting procedures to be performed to support those endpoints. The eCRF...
CRIO, a Boston-based technology firm streamlining clinical trials for sponsors, sites and patients, announced a fifth consecutive year of record contract bookings and revenue for 2021. Highlights for CRIO’s breakthrough 2021 include: Record YTD contract bookings and revenue – bookings up 80% year over year Over 300 new sites, including 5 of the top 10...
73% of sites reported using paper as the primary means of data collection In a 2018 CRIO site survey with over 100 respondents, sites reported that they use their Electronic Medical Record (EMR) primarily for patient recruitment purposes, but not for source data collection. 62% of site respondents reported that they use the EMR as...
Reflections on the Summit The 2021 Global Site Solutions Summit, hosted by the Society for Clinical Research Sites, was an amazing event. The first in-person event that our company has attended in 18 months, the Summit provided an opportunity for CRIO to meet new people and reconnect with clients and friends alike. Post-Pandemic Trends, Here...
What’s wrong with the way that most sites have been recording data for decades? While much of research data is still being collected on paper, digital adoption across source, regulatory and remote monitoring is rapidly increasing among sponsors, CROs, and research sites. Many of the challenges that Principal Investigators (PIs) face during the conduct of...
Clinical Research IO (CRIO)’s recent site survey showed that most sites have recovered business lost during the pandemic, are adjusting to the decentralized clinical trial model, and have implemented their own software in response. At the beginning of the pandemic, CRIO conducted a survey to look at the impact of coronavirus on research sites. By...
CRIO has been highlighted among the top solutions that help researchers track application deadlines, project milestones, and participant demographics. BOSTON, MA – August 24, 2021 – Clinical Research IO (CRIO), a Boston-based company working to transform the clinical research industry with the latest in the cloud and SaaS technology, has been named among the best...
Introducing CRIO Publisher, our highly anticipated new release! What’s good? CRIO eSource allows sites to build and save research-specific templates; capture data in real-time with protocol-specific edit checks; originate and respond to data queries; display automated audit trails; and share data with CRA’s without privacy concerns. What’s great CRIO Publisher allows eSource site networks, running the...
We know that clinical research changes are slow since it’s based on practices that require large, established data taxonomies. But at CRIO, we encourage pharma companies to adopt more gender-inclusive language. For example, some protocols may require only people assigned to one or the other sex at birth and if so, they should clearly state...
